The aim of this study was to investigate the development of IL-6 levels during psychosomatic treatment of individuals with PTSD and to identify modulating factors, with the overall goal of identifying a biomarker for treatment monitoring. The gene discussed is IL6; the disease is post-traumatic stress disorder.